Skip to main navigation Skip to search Skip to main content

CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy

  • J. Dawn Waters
  • , Carlos Sanchez
  • , Ayguen Sahin
  • , Diahnn Futalan
  • , David D. Gonda
  • , Justin K. Scheer
  • , Johnny Akers
  • , Kamalakannan Palanichamy
  • , Peter Waterman
  • , Arnab Chakravarti
  • , Ralph Weissleder
  • , Brent Morse
  • , Nick Marsh
  • , Eric Furfine
  • , Clark C. Chen
  • , Irvith Carvajal
  • , Bob S. Carter

Research output: Contribution to journal › Article › peer-review

10   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Keyphrases